Intech Investment Management LLC Has $536,000 Stake in Ingevity Co. (NYSE:NGVT)

Intech Investment Management LLC lifted its holdings in shares of Ingevity Co. (NYSE:NGVT) by 38.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 13,143 shares of the company’s stock after buying an additional 3,632 shares during the period. Intech Investment Management LLC’s holdings in Ingevity were worth $536,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. Natixis Advisors LLC grew its stake in shares of Ingevity by 6.7% in the third quarter. Natixis Advisors LLC now owns 27,908 shares of the company’s stock valued at $1,088,000 after buying an additional 1,751 shares in the last quarter. First Horizon Advisors Inc. grew its position in shares of Ingevity by 45.9% in the 3rd quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock valued at $34,000 after acquiring an additional 271 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Ingevity by 9.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 607,628 shares of the company’s stock valued at $23,697,000 after acquiring an additional 50,692 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in shares of Ingevity in the 3rd quarter valued at about $918,000. Finally, Advantage Alpha Capital Partners LP lifted its stake in Ingevity by 20.1% in the 3rd quarter. Advantage Alpha Capital Partners LP now owns 53,609 shares of the company’s stock valued at $2,091,000 after purchasing an additional 8,956 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on NGVT. StockNews.com downgraded Ingevity from a “buy” rating to a “hold” rating in a research report on Monday. BMO Capital Markets raised shares of Ingevity from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $62.00 to $65.00 in a research report on Wednesday, February 26th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $55.17.

Ingevity Stock Up 2.1 %

NGVT stock opened at $43.26 on Tuesday. Ingevity Co. has a fifty-two week low of $30.90 and a fifty-two week high of $56.30. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of -3.65 and a beta of 1.53. The business’s fifty day moving average price is $45.36 and its two-hundred day moving average price is $42.39.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.66. The business had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. On average, equities analysts anticipate that Ingevity Co. will post 4.45 earnings per share for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.